NextCell Pharma AB (FRA:65G)

NextCell Pharma AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is September - August.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2, 2025	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Market Capitalization	8	12	8	10	20	49
Market Cap Growth	-31.57%	43.77%	-21.57%	-48.86%	-58.29%	104.37%
Enterprise Value	4	10	6	5	10	34
Last Close Price	0.06	0.09	0.07	0.29	0.59	1.41
PS Ratio	7.73	11.78	8.23	8.87	35.05	111.90
PB Ratio	1.29	1.96	1.37	1.63	1.89	3.32
P/TBV Ratio	1.29	1.96	1.37	1.63	1.89	3.32
EV/Sales Ratio	4.15	10.27	6.39	4.34	17.86	78.06
Asset Turnover	0.14	0.14	0.13	0.13	0.04	0.05
Inventory Turnover	17.24	17.24	22.79	14.12	-	-
Quick Ratio	8.05	8.05	5.06	5.32	14.40	35.60
Current Ratio	10.02	10.02	6.15	6.67	15.40	37.02
Return on Equity (ROE)	-52.46%	-52.46%	-58.55%	-41.63%	-26.02%	-27.86%
Return on Assets (ROA)	-28.39%	-28.39%	-31.72%	-24.01%	-15.62%	-16.73%
Return on Capital (ROIC)	-33.48%	-33.48%	-37.65%	-26.80%	-16.48%	-17.60%
Return on Capital Employed (ROCE)	-50.30%	-50.30%	-60.50%	-52.10%	-29.80%	-16.40%
Earnings Yield	-41.11%	-26.96%	-45.20%	-32.17%	-15.83%	-4.93%
FCF Yield	-50.36%	-33.03%	-40.79%	-38.72%	-18.74%	-5.28%
Buyback Yield / Dilution	-87.22%	-87.22%	-18.72%	-	-13.05%	-53.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.